Our findings demonstrates that dysregulation of the miR-124-RAD51 axis contributes to chemotherapy responsiveness in GBM and further emphasizes the importance of combinational utilization of the functional miRNA and TMZ in the treatment of GBM in clinic. Here, RAD51 is linked to glioblastoma.